Table 1.
Background and treatments of the 47 patients
| dCRT | ESD-CRT | p -value | |
|---|---|---|---|
| Patients | n = 31 | n = 16 | |
| Age (median) | 33–80 (68) | 42–77 (65) | 0.31 |
| Gender (male:female) | 25:6 | 15:1 | 0.229 |
| Observation period (median) | 2.5–93.1 (34.2) | 6.5–78.4 (39.0) | 0.682 |
| Location | 0.959 | ||
| Cervical | 2 | 0 | |
| Upper thoracic | 1 | 1 | |
| Middle thoracic | 18 | 10 | |
| Lower thoracic | 10 | 5 | |
| Tumor depth | |||
| M3: 3 | M3: 2 | 0.297 | |
| SM1: 15 | SM1: 4 | ||
| SM2: 13 | SM2: 10 | ||
| Radiation field | |||
| Long T | 11 | 15 | 0.0001 |
| Short T | 3 | 1 | |
| Local | 17 | 0 | |
| Radiation dose (Gy) | |||
| 40 (−44) | 0 | 10 | 0.00001 |
| 54 | 1 | 0 | |
| 60 | 13 | 6 | |
| 60< | 17 | 0 | |
| Chemotherapy | |||
| Standard-dose FP | 12 | 10 | 0.046 |
| Low-dose FP | 6 | 4 | |
| Low-dose 5-FU | 9 | 2 | |
| Others | 4 | 0 |
Abbreviations: dCRT definitive chemoradiotherapy, ESD-CRT endoscopic submucosal dissection + chemoradiotherapy.